1. Home
  2. AVTX vs ANTA Comparison

AVTX vs ANTA Comparison

Compare AVTX & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • ANTA
  • Stock Information
  • Founded
  • AVTX 2011
  • ANTA 2022
  • Country
  • AVTX United States
  • ANTA Singapore
  • Employees
  • AVTX N/A
  • ANTA N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • ANTA Investment Bankers/Brokers/Service
  • Sector
  • AVTX Health Care
  • ANTA Finance
  • Exchange
  • AVTX Nasdaq
  • ANTA Nasdaq
  • Market Cap
  • AVTX 248.3M
  • ANTA 291.0M
  • IPO Year
  • AVTX 2015
  • ANTA 2025
  • Fundamental
  • Price
  • AVTX $15.14
  • ANTA $10.75
  • Analyst Decision
  • AVTX Strong Buy
  • ANTA Strong Buy
  • Analyst Count
  • AVTX 9
  • ANTA 3
  • Target Price
  • AVTX $30.14
  • ANTA $17.50
  • AVG Volume (30 Days)
  • AVTX 412.1K
  • ANTA 8.2K
  • Earning Date
  • AVTX 11-06-2025
  • ANTA 11-10-2025
  • Dividend Yield
  • AVTX N/A
  • ANTA N/A
  • EPS Growth
  • AVTX N/A
  • ANTA 669.18
  • EPS
  • AVTX N/A
  • ANTA 0.47
  • Revenue
  • AVTX $192,000.00
  • ANTA $65,033,103.00
  • Revenue This Year
  • AVTX N/A
  • ANTA $65.94
  • Revenue Next Year
  • AVTX N/A
  • ANTA $59.39
  • P/E Ratio
  • AVTX N/A
  • ANTA $21.96
  • Revenue Growth
  • AVTX N/A
  • ANTA 63.28
  • 52 Week Low
  • AVTX $3.39
  • ANTA $9.50
  • 52 Week High
  • AVTX $19.41
  • ANTA $27.72
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 48.12
  • ANTA N/A
  • Support Level
  • AVTX $14.16
  • ANTA N/A
  • Resistance Level
  • AVTX $16.03
  • ANTA N/A
  • Average True Range (ATR)
  • AVTX 1.27
  • ANTA 0.00
  • MACD
  • AVTX -0.42
  • ANTA 0.00
  • Stochastic Oscillator
  • AVTX 23.40
  • ANTA 0.00

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

Share on Social Networks: